1 - 25 of 207 results for author:"Roth J." in Literature citations
Results Customize
› Repeat search in UniProtKB (178)
| Mrp14 deficiency ameliorates amyloid beta burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. Kummer M.P., Vogl T., Axt D., Griep A., Vieira-Saecker A., Jessen F., Gelpi E., Roth J., Heneka M.T. J. Neurosci. 32:17824-17829(2012) · Mapped (4) |
| The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis. Petersen B., Wolf M., Austermann J., van Lent P., Foell D., Ahlmann M., Kupas V., Loser K., Sorg C., Roth J. et al. EMBO J. 32:100-111(2013) · Mapped (4) |
| Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis. Achouiti A., Vogl T., Urban C.F., Rohm M., Hommes T.J., van Zoelen M.A., Florquin S., Roth J., van 't Veer C., de Vos A.F. et al. PLoS Pathog. 8:e1002987-e1002987(2012) · Mapped (2) |
| Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent. Riva M., Kaellberg E., Bjoerk P., Hancz D., Vogl T., Roth J., Ivars F., Leanderson T. |
| Novel role of PKR in inflammasome activation and HMGB1 release. Lu B., Nakamura T., Inouye K., Li J., Tang Y., Lundbaeck P., Valdes-Ferrer S.I., Olofsson P.S., Kalb T., Roth J. et al. |
| Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Kim J.Y., Hildebrandt M.A., Pu X., Ye Y., Correa A.M., Vaporciyan A.A., Wu X., Roth J.A. Ann. Thorac. Surg. 94:1079-1084(2012) · Mapped (6) |
| S100A9 interaction with TLR4 promotes tumor growth. Kallberg E., Vogl T., Liberg D., Olsson A., Bjork P., Wikstrom P., Bergh A., Roth J., Ivars F., Leanderson T. PLoS ONE 7:e34207-e34207(2012) · Mapped (26) |
| Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. PD GWAS Consortium Ann. Neurol. 71:370-384(2012) · Mapped (1) |
| CREMalpha overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity. Lippe R., Ohl K., Varga G., Rauen T., Crispin J.C., Juang Y.T., Kuerten S., Tacke F., Wolf M., Roebrock K. et al. J Mol Cell Biol 4:121-123(2012) · Mapped (24) |
| Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation. Garrick M.D., Zhao L., Roth J.A., Jiang H., Feng J., Foot N.J., Dalton H., Kumar S., Garrick L.M. Biometals 25:787-793(2012) · Mapped (3) |
| Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Kneidl J., Loffler B., Erat M.C., Kalinka J., Peters G., Roth J., Barczyk K. Cell. Microbiol. 14:914-936(2012) · Mapped (3) |
| Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. Horn M., Bertling A., Brodde M.F., Muller A., Roth J., Van Aken H., Jurk K., Heilmann C., Peters G., Kehrel B.E. J. Thromb. Haemost. 10:647-661(2012) · Mapped (17) |
| Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. Trevaskis J.L., Griffin P.S., Wittmer C., Neuschwander-Tetri B.A., Brunt E.M., Dolman C.S., Erickson M.R., Napora J., Parkes D.G., Roth J.D. Am. J. Physiol. Gastrointest. Liver Physiol. 302:G762-72(2012) · Mapped (9) |
| O-GlcNAc modification of PPARgamma reduces its transcriptional activity. Ji S., Park S.Y., Roth J., Kim H.S., Cho J.W. Biochem. Biophys. Res. Commun. 417:1158-1163(2012) · UniProtKB (1) · Mapped (9) |
| Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. van Lent P.L., Blom A.B., Schelbergen R.F., Sloetjes A., Lafeber F.P., Lems W.F., Cats H., Vogl T., Roth J., van den Berg W.B. Arthritis Rheum. 64:1466-1476(2012) · Mapped (2) |
| Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Schelbergen R.F., Blom A.B., van den Bosch M.H., Sloetjes A., Abdollahi-Roodsaz S., Schreurs B.W., Mort J.S., Vogl T., Roth J., van den Berg W.B. et al. Arthritis Rheum. 64:1477-1487(2012) · Mapped (1) |
| The role of PKR/eIF2alpha signaling pathway in prognosis of non-small cell lung cancer. He Y., Correa A.M., Raso M.G., Hofstetter W.L., Fang B., Behrens C., Roth J.A., Zhou Y., Yu L., Wistuba I.I. et al. PLoS ONE 6:e24855-e24855(2011) · Mapped (8) |
| Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36. Welsch J., Hubschle T., Murgott J., Kirschning C., Rummel C., Gerstberger R., Roth J. Innate Immun 18:541-559(2012) · Mapped (2) |
| A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. Crist R.C., Roth J.J., Waldman S.A., Buchberg A.M. PLoS ONE 6:e23665-e23665(2011) · Mapped (12) |
| A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus. Rauen T., Benedyk K., Juang Y.T., Kerkhoff C., Kyttaris V.C., Roth J., Tsokos G.C., Tenbrock K. J. Biol. Chem. 286:32366-32372(2011) · Mapped (6) |
| Regulation of tumor suppressor gene FUS1 expression by the untranslated regions of mRNA in human lung cancer cells. Lin J., Xu K., Gitanjali J., Roth J.A., Ji L. Biochem. Biophys. Res. Commun. 410:235-241(2011) · Mapped (2) |
| Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-gamma on human neutrophils and monocytes. Shpacovitch V.M., Feld M., Holzinger D., Kido M., Hollenberg M.D., Levi-Schaffer F., Vergnolle N., Ludwig S., Roth J., Luger T. et al. Immunology 133:329-339(2011) · UniProtKB (1) |
| Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. Wu X., Ye Y., Rosell R., Amos C.I., Stewart D.J., Hildebrandt M.A., Roth J.A., Minna J.D., Gu J., Lin J. et al. J. Natl. Cancer Inst. 103:817-825(2011) · Mapped (3) |
| STAT3 mediates resistance to MEK inhibitor through microRNA miR-17. Dai B., Meng J., Peyton M., Girard L., Bornmann W.G., Ji L., Minna J.D., Fang B., Roth J.A. Cancer Res. 71:3658-3668(2011) · Mapped (14) |
| Protein O-GlcNAcylation regulates Drosophila growth through the insulin signaling pathway. Park S., Park S.H., Baek J.Y., Jy Y.J., Kim K.S., Roth J., Cho J.W., Choe K.M. Cell. Mol. Life Sci. 68:3377-3384(2011) · Mapped (13) |